|
⚲
|
| Keyboard |
| Franklyn Prendergast | |
|---|---|
| Firm | |
| Address | 350 Technology Drive Pittsburgh, PA 15219 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Neubase Therapeutics Inc | 021-486254 | Director | 5.0 M of 5.0 M |
||
| Cancer Genetics Inc | 021-388238 | Director | 10.0 M of 10.0 M |
||
| Mill Creek Life Sciences LLC | 021-332368 | Director | of 5.0 M |
||
| Liquid Bioscience Inc | 021-324670 | Director | 0.1 M of 21.0 M |
||
| Liquid Bioscience Inc | 021-318023 | Director | 0.1 M of 10.0 M |
||
| Liquid Bioscience Inc | 021-294218 | Director | 40.0 M of 40.0 M |
||
| Cancer Genetics Inc | 021-283388 | Director | 6.0 M of 6.0 M |
||
| Cancer Genetics Inc | 021-275654 | Director | 5.5 M of 5.5 M |
||
| Cancer Genetics Inc | 021-263863 | Director | 5.0 M of 5.0 M |
||
| Ativa Medical Corp | 021-197504 | Director | 0.2 M of 7.0 M |
||
| Ativa Medical Corp | 021-172349 | Director | 3.4 M of 10.0 M |
||
| Cernostics Inc | 021-142744 | Director | 2.6 M of 2.7 M |
||
| Cernostics Pathology Inc | 021-135479 | Director | 0.4 M of 0.4 M |
||
| Cellumen Inc | 021-66503 | Director | 0.2 M of 0.5 M |
||